Cargando…
Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia
This study assessed the proportion of ABO blood groups and clinical characteristics among Saudi patients with coronavirus disease 2019 (COVID-19) in Jazan, Saudi Arabia. This retrospective cohort study included 404 Saudi adults with COVID-19, confirmed by the real-time reverse transcription-polymera...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322480/ https://www.ncbi.nlm.nih.gov/pubmed/34397712 http://dx.doi.org/10.1097/MD.0000000000026738 |
_version_ | 1783731056933863424 |
---|---|
author | Badedi, Mohammed Alnami, Awaji Darraj, Hussain Alrajhi, Anas Mutawwam, Dhayf-Alrahman Somaily, Majed Alshareefi, Ali Muhajir, Abdulrahman Majrabi, Yasser |
author_facet | Badedi, Mohammed Alnami, Awaji Darraj, Hussain Alrajhi, Anas Mutawwam, Dhayf-Alrahman Somaily, Majed Alshareefi, Ali Muhajir, Abdulrahman Majrabi, Yasser |
author_sort | Badedi, Mohammed |
collection | PubMed |
description | This study assessed the proportion of ABO blood groups and clinical characteristics among Saudi patients with coronavirus disease 2019 (COVID-19) in Jazan, Saudi Arabia. This retrospective cohort study included 404 Saudi adults with COVID-19, confirmed by the real-time reverse transcription-polymerase chain reaction. The participants were selected randomly between July 1, 2020, and July 31, 2020, from the Health Electronic Surveillance Network system, which contains the primary data on COVID-19 infections in Jazan. Blood type O (62.4%) represented the highest proportion in COVID-19 Saudi patients followed by the other blood groups which distributed as follows: blood type A (25.5%), blood type B (10.1%), and blood type AB (2%). Men, and people aged 18–44 years, represented the higher percentage than women and those of a younger age. The majority of the patients with COVID-19 had clinical symptoms (88.4%), and the remainder (11.6%) were asymptomatic. Ninety four percent of the patients had mild COVID-19 symptoms and self-isolated at home. Only 6.4% of the cases were severe and admitted to hospital. There was no significant association between a specific ABO blood group and COVID-19 clinical symptoms (P = .950), incubation period (P = .780), disease duration (P = .430), and disease severity (P = .340). Old age and diabetes were the significant predictors of COVID-19 severity and hospital admission (P = .010). Blood group O represented the highest proportion of COVID-19 Saudi patients as it is the most common blood group in Saudi individuals in Jazan. However, no specific blood group was associated with COVID-19 severity and hospital admission. Old age and diabetes mellitus were shown to be significant predictors of severe COVID-19 and hospital admission. |
format | Online Article Text |
id | pubmed-8322480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-83224802021-08-02 Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia Badedi, Mohammed Alnami, Awaji Darraj, Hussain Alrajhi, Anas Mutawwam, Dhayf-Alrahman Somaily, Majed Alshareefi, Ali Muhajir, Abdulrahman Majrabi, Yasser Medicine (Baltimore) 4400 This study assessed the proportion of ABO blood groups and clinical characteristics among Saudi patients with coronavirus disease 2019 (COVID-19) in Jazan, Saudi Arabia. This retrospective cohort study included 404 Saudi adults with COVID-19, confirmed by the real-time reverse transcription-polymerase chain reaction. The participants were selected randomly between July 1, 2020, and July 31, 2020, from the Health Electronic Surveillance Network system, which contains the primary data on COVID-19 infections in Jazan. Blood type O (62.4%) represented the highest proportion in COVID-19 Saudi patients followed by the other blood groups which distributed as follows: blood type A (25.5%), blood type B (10.1%), and blood type AB (2%). Men, and people aged 18–44 years, represented the higher percentage than women and those of a younger age. The majority of the patients with COVID-19 had clinical symptoms (88.4%), and the remainder (11.6%) were asymptomatic. Ninety four percent of the patients had mild COVID-19 symptoms and self-isolated at home. Only 6.4% of the cases were severe and admitted to hospital. There was no significant association between a specific ABO blood group and COVID-19 clinical symptoms (P = .950), incubation period (P = .780), disease duration (P = .430), and disease severity (P = .340). Old age and diabetes were the significant predictors of COVID-19 severity and hospital admission (P = .010). Blood group O represented the highest proportion of COVID-19 Saudi patients as it is the most common blood group in Saudi individuals in Jazan. However, no specific blood group was associated with COVID-19 severity and hospital admission. Old age and diabetes mellitus were shown to be significant predictors of severe COVID-19 and hospital admission. Lippincott Williams & Wilkins 2021-07-30 /pmc/articles/PMC8322480/ /pubmed/34397712 http://dx.doi.org/10.1097/MD.0000000000026738 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | 4400 Badedi, Mohammed Alnami, Awaji Darraj, Hussain Alrajhi, Anas Mutawwam, Dhayf-Alrahman Somaily, Majed Alshareefi, Ali Muhajir, Abdulrahman Majrabi, Yasser Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia |
title | Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia |
title_full | Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia |
title_fullStr | Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia |
title_full_unstemmed | Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia |
title_short | Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia |
title_sort | clinical characteristics and abo blood groups in covid-19 patients, saudi arabia |
topic | 4400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322480/ https://www.ncbi.nlm.nih.gov/pubmed/34397712 http://dx.doi.org/10.1097/MD.0000000000026738 |
work_keys_str_mv | AT badedimohammed clinicalcharacteristicsandabobloodgroupsincovid19patientssaudiarabia AT alnamiawaji clinicalcharacteristicsandabobloodgroupsincovid19patientssaudiarabia AT darrajhussain clinicalcharacteristicsandabobloodgroupsincovid19patientssaudiarabia AT alrajhianas clinicalcharacteristicsandabobloodgroupsincovid19patientssaudiarabia AT mutawwamdhayfalrahman clinicalcharacteristicsandabobloodgroupsincovid19patientssaudiarabia AT somailymajed clinicalcharacteristicsandabobloodgroupsincovid19patientssaudiarabia AT alshareefiali clinicalcharacteristicsandabobloodgroupsincovid19patientssaudiarabia AT muhajirabdulrahman clinicalcharacteristicsandabobloodgroupsincovid19patientssaudiarabia AT majrabiyasser clinicalcharacteristicsandabobloodgroupsincovid19patientssaudiarabia |